[mBio] Investigators followed Salmonella and Shigella infections of human enteroids and colonoids by time-lapse imaging to pinpoint virulence factor modules that shape the divergent epithelial colonization strategies.
[Communications Biology] scRNAseq on organoids revealed the effects of UBE3A disruption on cell type-specific compositions and transcriptomic alterations.
[Nature Communications] The authors found that contact with human endothelial cells increases human neural stem and progenitor cell type B cells leading to generation of a human type B single-cell RNA sequencing dataset.
[JCI Insight] Using integrative transcriptomics analysis and smooth muscle specific lineage tracing mice, scientists demonstrated NEXN is highly expressed in vascular smooth muscle cells (VSMCs), and the expression of NEXN is significantly reduced during the phenotypic transformation of VSMCs and intimal hyperplasia induced by vascular injury.
[Experimental & Molecular Medicine] Researchers identified the 5-HT receptor 2b (Htr2b) as a critical regulator of insulin sensitivity and energy metabolism in the skeletal muscle.
[American Journal of Physiology-Regulatory Integrative and Comparative Physiology] Scientists showed that pediatric brain tumors stunt muscle development in young mice. GL261 glioblastoma cells cause myotube atrophy, reduced carcass, heart, and fat mass, and impeded skeletal muscle growth.
[Nature Biomedical Engineering] Investigators generated transgenic mice with Cre-regulated and constitutive expression of enhanced Acidaminococcus sp. Cas12a, which robustly generates compound genotypes, including diverse cancers driven by inactivation of trios of tumour suppressor genes or an oncogenic translocation.
[Nature Medicine] Researchers reported the dose escalation and exploration phases of a Phase I trial investigating intracerebroventricular delivery of bivalent CAR T cells targeting epidermal growth factor receptor (EGFR) epitope 806 and interleukin-13 receptor alpha 2 (IL-13Rα2), or CART-EGFR-IL13Rα2 cells, in patients with EGFR-amplified recurrent glioblastoma.
[Cancer Immunology Research] Investigators showed that CAR T cells from patients treated with FDA-approved CAR T-cell products express members of the VEGF signaling pathway and this expression is correlated with patient non-response.